<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03617770</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0762</org_study_id>
    <secondary_id>P30DK092949</secondary_id>
    <nct_id>NCT03617770</nct_id>
  </id_info>
  <brief_title>A Sleep Intervention in Type 1 Diabetes</brief_title>
  <official_title>A Sleep Intervention to Improve Glycemic Control and Reduce Diabetes Distress in Working Adults With Type 1 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Insufficient sleep and sleep irregularity (variability in sleep duration) are increasingly&#xD;
      recognized as important contributors to glucose control and diabetes distress in type 1&#xD;
      diabetes (T1D). Up to 40% of adults with T1D had a sleep duration less than 6-6.5 hours per&#xD;
      night. Diabetes distress is reported (40% prevalence) in individuals with T1D and is&#xD;
      associated with poor glucose control. Despite findings that sleep disturbances are common in&#xD;
      T1D, the current understanding of the effects of strategies to improve sleep on diabetes&#xD;
      distress, and glucose control is limited. The purpose of this pilot study is to evaluate the&#xD;
      effects of a sleep intervention on sleep duration, diabetes distress and glucose control in&#xD;
      individuals with T1D and habitual short sleep. A randomized controlled trial in 20 adults&#xD;
      aged 18 to 65 years with T1D is proposed. Eligible participants will be randomly assigned to&#xD;
      a sleep intervention group or a control group. Differences between the two groups on the&#xD;
      outcomes of sleep duration, diabetes distress and glucose control will be evaluated. Findings&#xD;
      from this proposed pilot study will serve as the foundation for a larger clinical trial to&#xD;
      improve sleep, reduce diabetes distress, and improve glucose control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Insufficient sleep and sleep irregularity (variability in sleep duration) are increasingly&#xD;
      recognized as important contributors to glycemic control and diabetes distress in type 1&#xD;
      diabetes (T1D). Up to 40% of adults with T1D had a sleep duration &lt; 6-6.5 hours per night,&#xD;
      either by self-report or objectively assessed actigraphy. Diabetes distress is reported (40%&#xD;
      prevalence) in individuals with T1D and is associated with poor glycemic control. Despite&#xD;
      findings that sleep disturbances are common in T1D, the current understanding of the effects&#xD;
      of sleep optimization on sleep, diabetes distress, and glycemic control is limited. The&#xD;
      purpose of this pilot and feasibility trial is to evaluate the effects of a T1D-specific&#xD;
      sleep optimization intervention (Sleep-Opt-In) on the outcomes of sleep, diabetes distress&#xD;
      and glycemic control in individuals with T1D and habitual short sleep. The specific aims are&#xD;
      to determine if Sleep-Opt-In will: 1) be feasible and acceptable to the target population; 2)&#xD;
      result in improved sleep duration and regularity; 3) result in improved glycemic control; and&#xD;
      4) lower diabetes distress. To achieve these aims, a randomized controlled trial in 20 adults&#xD;
      aged 18 to 65 years with T1D is proposed. Participants will be screened for habitual sleep&#xD;
      duration &lt; 6.5 hours per night. Eligible subjects will be randomized to the T1D-Sleep-Opt-In&#xD;
      group or attention control group. A one-week run-in period is planned, with baseline measures&#xD;
      of sleep (duration and regularity), glycemia (A1C, fructosamine, glycemic variability), and&#xD;
      diabetes distress (Diabetes Distress Scale). The T1D-Sleep-Opt-In will entail a novel&#xD;
      technology-assisted behavioral sleep extension intervention developed to leverage rapidly&#xD;
      increasing public interest in sleep tracking by consumers (+500% in 3 years). This technology&#xD;
      employs four elements: a wearable sleep tracker, didactic content, an interactive smartphone&#xD;
      application, and brief telephone counseling. The intervention will be T1D-specific by&#xD;
      addressing T1D-related sleep issues such as nocturnal hypoglycemia. The attention control&#xD;
      group will participate in a healthy living information program. At completion (Week 8) and&#xD;
      post-program (Weeks 12 and 24), baseline measures will be repeated to determine differences&#xD;
      between the two groups and sustainability of the intervention. Findings from this proposed&#xD;
      pilot study will serve as the foundation for a larger clinical trial to improve sleep, reduce&#xD;
      diabetes distress, and improve glycemic control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 9, 2019</start_date>
  <completion_date type="Actual">November 20, 2019</completion_date>
  <primary_completion_date type="Actual">November 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Sleep optimization intervention will be compared to a healthy living attention control</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep Duration</measure>
    <time_frame>Assessing change between two time points:Week 0 to week 8</time_frame>
    <description>change in minutes of sleep (actigraphy-derived)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Regularity</measure>
    <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
    <description>Change in sleep regularity (variability)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>Change between two time points, week 0 to week 8</time_frame>
    <description>HbA1c (A1C%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose Variability</measure>
    <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
    <description>Change in glucose variability (CV%) (continuous glucose monitor derived)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diabetes Distress</measure>
    <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
    <description>Change in Diabetes Distress Scale score, 6-point, 17-item Likert scale. The 17 items are summed. The sum score is divided by 17 to provide a mean item score. Higher scores indicate greater distress. Score interpretation:&#xD;
&lt; 2.0 = little distress 2.0-2.9 = moderate distress 3.0 or greater = hah distress</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Short Sleep Phenotype</condition>
  <condition>Type1diabetes</condition>
  <arm_group>
    <arm_group_label>Sleep-Opt-In</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sleep optimization intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Living</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Health education</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sleep Opt-In</intervention_name>
    <description>8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
    <arm_group_label>Sleep-Opt-In</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Healthy Living</intervention_name>
    <description>8-week intervention that includes weekly telephone counseling on healthy living.</description>
    <arm_group_label>Healthy Living</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  type 1 diabetes for one year or more&#xD;
&#xD;
          -  self-reported habitual sleep duration less than 6.5 hours per night during work- or&#xD;
             weekdays&#xD;
&#xD;
          -  own a smartphone.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  insomnia&#xD;
&#xD;
          -  sleep apnea&#xD;
&#xD;
          -  severe hypoglycemia within past 6 months&#xD;
&#xD;
          -  treated with an insulin pump with hybrid closed-loop features&#xD;
&#xD;
          -  rotating shift or night shift work&#xD;
&#xD;
          -  estimated glomerular filtration rate less than 45 ml/min&#xD;
&#xD;
          -  heart failure&#xD;
&#xD;
          -  cirrhosis&#xD;
&#xD;
          -  chronic obstructive pulmonary disease requiring oxygen&#xD;
&#xD;
          -  actively treated for cancer or psychiatric problem&#xD;
&#xD;
          -  history of stroke&#xD;
&#xD;
          -  pregnant or planning pregnancy&#xD;
&#xD;
          -  HbA1c 10% or higher.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pamela Martyn-Nemeth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>July 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <results_first_submitted>July 20, 2020</results_first_submitted>
  <results_first_submitted_qc>February 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 5, 2021</results_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Pamela Martyn-Nemeth</investigator_full_name>
    <investigator_title>Assistant Professor Biobehavioral Health Science College of Nursing</investigator_title>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>glycemic control</keyword>
  <keyword>sleep</keyword>
  <keyword>diabetes distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 14, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT03617770/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sleep-Opt-In</title>
          <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
        </group>
        <group group_id="P2">
          <title>Healthy Living</title>
          <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9">9</participants>
                <participants group_id="P2" count="5">5</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8">8</participants>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sleep-Opt-In</title>
          <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
        </group>
        <group group_id="B2">
          <title>Healthy Living</title>
          <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.1" spread="7.1"/>
                    <measurement group_id="B2" value="30.0" spread="7.6"/>
                    <measurement group_id="B3" value="30.1" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sleep Duration</title>
        <description>change in minutes of sleep (actigraphy-derived)</description>
        <time_frame>Assessing change between two time points:Week 0 to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep-Opt-In</title>
            <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
          </group>
          <group group_id="O2">
            <title>Healthy Living</title>
            <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Duration</title>
          <description>change in minutes of sleep (actigraphy-derived)</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="385" spread="40"/>
                    <measurement group_id="O2" value="388" spread="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Regularity</title>
        <description>Change in sleep regularity (variability)</description>
        <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep-Opt-In</title>
            <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
          </group>
          <group group_id="O2">
            <title>Healthy Living</title>
            <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Regularity</title>
          <description>Change in sleep regularity (variability)</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" spread="20"/>
                    <measurement group_id="O2" value="56" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HbA1c</title>
        <description>HbA1c (A1C%)</description>
        <time_frame>Change between two time points, week 0 to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep-Opt-In</title>
            <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
          </group>
          <group group_id="O2">
            <title>Healthy Living</title>
            <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
          </group>
        </group_list>
        <measure>
          <title>HbA1c</title>
          <description>HbA1c (A1C%)</description>
          <units>% of glucose saturation on hemoglobin</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.48" spread="0.74"/>
                    <measurement group_id="O2" value="6.7" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucose Variability</title>
        <description>Change in glucose variability (CV%) (continuous glucose monitor derived)</description>
        <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep-Opt-In</title>
            <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
          </group>
          <group group_id="O2">
            <title>Healthy Living</title>
            <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose Variability</title>
          <description>Change in glucose variability (CV%) (continuous glucose monitor derived)</description>
          <units>percentage of CV</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.4" spread="4.6"/>
                    <measurement group_id="O2" value="31.6" spread="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diabetes Distress</title>
        <description>Change in Diabetes Distress Scale score, 6-point, 17-item Likert scale. The 17 items are summed. The sum score is divided by 17 to provide a mean item score. Higher scores indicate greater distress. Score interpretation:&#xD;
&lt; 2.0 = little distress 2.0-2.9 = moderate distress 3.0 or greater = hah distress</description>
        <time_frame>Assessing change between two time points: from week 0 to week 8</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sleep-Opt-In</title>
            <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
          </group>
          <group group_id="O2">
            <title>Healthy Living</title>
            <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
          </group>
        </group_list>
        <measure>
          <title>Diabetes Distress</title>
          <description>Change in Diabetes Distress Scale score, 6-point, 17-item Likert scale. The 17 items are summed. The sum score is divided by 17 to provide a mean item score. Higher scores indicate greater distress. Score interpretation:&#xD;
&lt; 2.0 = little distress 2.0-2.9 = moderate distress 3.0 or greater = hah distress</description>
          <units>change in score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.23"/>
                    <measurement group_id="O2" value="3.1" spread="1.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sleep-Opt-In</title>
          <description>Sleep optimization intervention&#xD;
Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling</description>
        </group>
        <group group_id="E2">
          <title>Healthy Living</title>
          <description>Health education&#xD;
Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Pamela Martyn-Nemeth</name_or_title>
      <organization>University of Illinois at Chicago</organization>
      <phone>3129967903</phone>
      <email>pmartyn@uic.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

